Related Experiment Video

Updated: May 21, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

[Management of cardiac failure: a guilty one easy to target!]

Sandra Bieler1, François Mach

  • 1Service de médecine interne générale, HUG, 121 I Genève 14. sandra.bieler@hcuge.ch

Revue Medicale Suisse
|June 29, 2012
PubMed

Insights

High heart rate increases cardiovascular risk. Ivabradine, a heart rate-lowering medication, has been studied for its effects on cardiovascular outcomes in patients with chronic heart failure.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta blockers and ACE inhibitors show benefits in chronic heart failure, potentially due to heart rate reduction.
  • Elevated heart rate is linked to cardiovascular morbidity and mortality in various populations, including those with hypertension and heart failure.

Purpose of the Study:

  • To explore the role of heart rate-lowering properties in the efficacy of heart failure treatments.
  • To review the cardiovascular effects of ivabradine, a specific sino-atrial node If current inhibitor.

Main Methods:

  • Discusses the clinical studies BEAUTIFUL and SHIFT, which investigated ivabradine's impact on resting heart rate and cardiovascular outcomes.
  • Focuses on ivabradine's mechanism as a selective If current inhibitor without other cardiovascular effects.

Main Results:

  • Ivabradine effectively reduces resting heart rate.
  • The studies evaluated the impact of this heart rate reduction on cardiovascular outcomes.

Conclusions:

  • Heart rate-lowering strategies, exemplified by ivabradine, may offer significant cardiovascular benefits.
  • Further understanding of ivabradine's role in managing chronic heart failure is supported by clinical trial data.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...